Skip to main content

ECG Collection 3

ECG Collection 3: 

(Paper speed is 25mm/sec and voltage calibration is 10mm/mV.
Click on ECG image to enlarge.)
  1. A 50 year old male presented with dyspnea
  2.  A 43 year old man with chest pain for 3 hours
  3. A 57 year old male with palpitations
  4. A 57 year old male admitted in critical care unit with pneumonia
  5. A 58 year old male complaining of weakness
  6.  A 53 year old female with dyspnea diagnosed as having rheumatic heart disease
  7. A 45 year old male, smoker, presented with chest pain and profuse sweating
  8.  A 63 year old male with vomiting and hypotension
  9. A 50 year old man came for preop cardiac evaluation with this ECG
  10. A 23 year old young lady came for cardiac evaluation
  11. A 67 year old male with chest pain
  12. A 78 year old woman with dizziness and profuse sweating
  13. A 24 year lady with history of palpitations
  14. A 70 year old man with chest pain
  15. A 58 year old man known case of end stage renal disease had this ECG just before dialysis 
  16. A 22 year old lady found unconscious after a suicide attempt, empty bottle of pills found near her
  17. A 55 year old man with chest pain and palpitations
  18. A 78 year old lady with chest pain
  19. A 26 year old man referred to you because of a murmur heard by his GP, whats your diagnosis?
  20. A 43 year old lady with palpitations
  21. A 57 year old lady complaining of palpitations on day one of lap chole
  22.  A 9 year old boy with this ECG
  23. A 75 year old male presented to ER department with one hour history of chest pain
  24. A 100 year old man with palpitations
  25. A 87 year old male came for preop cardiac evaluation 

End of this section
Go to Main ECG page to view more collections

Comments

Popular posts from this blog

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 ESC Guidelines on INR Targets in Mechanical Valves

  2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...